Invesco’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.09M | Buy |
47,884
+5,809
| +14% | +$254K | ﹤0.01% | 2562 |
|
|
2025
Q1 | $1.15M | Buy |
42,075
+11,343
| +37% | +$310K | ﹤0.01% | 2766 |
|
|
2024
Q4 | $1.24M | Sell |
30,732
-133,187
| -81% | -$5.36M | ﹤0.01% | 2821 |
|
|
2024
Q3 | $7.76M | Buy |
163,919
+134,085
| +449% | +$6.35M | ﹤0.01% | 1973 |
|
|
2024
Q2 | $891K | Sell |
29,834
-83,533
| -74% | -$2.49M | ﹤0.01% | 2984 |
|
|
2024
Q1 | $4.56M | Buy |
113,367
+85,278
| +304% | +$3.43M | ﹤0.01% | 2292 |
|
|
2023
Q4 | $715K | Sell |
28,089
-8,538
| -23% | -$217K | ﹤0.01% | 3031 |
|
|
2023
Q3 | $509K | Buy |
36,627
+6,197
| +20% | +$86.1K | ﹤0.01% | 3182 |
|
|
2023
Q2 | $700K | Sell |
30,430
-159,056
| -84% | -$3.66M | ﹤0.01% | 3057 |
|
|
2023
Q1 | $5.61M | Buy |
189,486
+175,993
| +1,304% | +$5.21M | ﹤0.01% | 2158 |
|
|
2022
Q4 | $337K | Sell |
13,493
-3
| -0% | -$75 | ﹤0.01% | 3438 |
|
|
2022
Q3 | $294K | Sell |
13,496
-67
| -0.5% | -$1.46K | ﹤0.01% | 3503 |
|
|
2022
Q2 | $267K | Sell |
13,563
-1,808
| -12% | -$35.6K | ﹤0.01% | 3590 |
|
|
2022
Q1 | $650K | Buy |
15,371
+146
| +1% | +$6.17K | ﹤0.01% | 3240 |
|
|
2021
Q4 | $967K | Sell |
15,225
-171
| -1% | -$10.9K | ﹤0.01% | 3049 |
|
|
2021
Q3 | $904K | Buy |
15,396
+6,132
| +66% | +$360K | ﹤0.01% | 3125 |
|
|
2021
Q2 | $450K | Buy |
+9,264
| New | +$450K | ﹤0.01% | 3435 |
|